Antibody response against Influenza and SARS-CoV-2 antigens

ABSTRACT: A protein microarray was used to measure antibody response in the plasma of mice immunized with mRNA vaccine formulations at d14 and d28 post prime immunizations (n = 53). The results demonstrate antigen- specific antibody response was elicited by a bivalent mRNA vaccine to combat Influenza and SARS-CoV-2 infections.

ORGANISM(S): Influenza A virus Mus musculus Severe acute respiratory syndrome coronavirus 2

PROVIDER: GSE295393 | GEO | 2025/04/23

REPOSITORIES: GEO